Physician profile
Frederick Charles David
NPI 1982793808
$7,069.26
in general payments reported to CMS, 2019-2025
50 companies · $989 in 2025
The $989 reported for 2025 was more than what 83% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $458 · 2021: $1,713 · 2022: $1,257 · 2023: $489 · 2024: $718 · 2025: $989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116 · Education: $79.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.09 |
| Education | $79.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $679.95 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| Daiichi Sankyo INC. | $538.70 | 2019-2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $440.02 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Regeneron Healthcare Solutions, INC. | $405.12 | 2021-2025 | Libtayo |
| Lilly USA, LLC | $389.79 | 2019-2025 | Jaypirca, Verzenio |
| Janssen Biotech, INC. | $378.87 | 2019-2025 | Erleada, Akeega, Balversa |
| Genzyme Corporation | $376.23 | 2019-2022 | |
| Amgen INC. | $355.00 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $308.36 | 2019-2024 | Opdivo |
| Glaxosmithkline, LLC. | $271.52 | 2020-2024 | Ojjaara |
| Progenics Pharmaceuticals, INC. | $266.40 | 2022-2023 | Pylarify |
| Novartis Pharmaceuticals Corporation | $237.80 | 2019-2025 | |
| Eisai INC. | $202.70 | 2019-2022 | |
| Genentech USA, INC. | $188.06 | 2021-2025 | Tecentriq Hybreza, Itovebi |
| Bayer Healthcare Pharmaceuticals INC. | $180.89 | 2019-2025 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.